Climb Bio (CLYM)
NASDAQ:CLYM
US Market
Holding CLYM?
Track your performance easily

Climb Bio (CLYM) Financial Statements

48 Followers

Climb Bio Financial Overview

Climb Bio's market cap is currently ―. The company's EPS TTM is $-2.148; its P/E ratio is -1.77; Climb Bio is scheduled to report earnings on May 19, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 33.00K$ 33.00K---
Gross Profit$ 33.00K$ 33.00K---
EBIT$ -8.89M$ -54.89M$ -3.00M$ -5.00M$ -5.22M
EBITDA$ -8.89M$ -54.89M$ -3.00M$ -5.00M$ -5.22M
Net Income Common Stockholders$ -8.89M$ -54.89M$ -1.70M$ -3.97M$ -5.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 193.35M$ 223.14M$ 105.00M$ 107.43M$ 102.63M
Total Assets$ 222.20M$ 226.02M$ 109.33M$ 112.73M$ 116.27M
Total Debt$ 58.00K$ 100.00K$ 225.00K$ 459.00K$ 585.00K
Net Debt$ -193.29M$ -223.04M$ -104.78M$ -106.97M$ -102.05M
Total Liabilities$ 3.42M$ 3.74M$ 2.95M$ 2.99M$ 3.77M
Stockholders Equity$ 218.78M$ 222.28M$ 106.36M$ 109.74M$ 112.50M
Cash Flow-
Free Cash Flow$ -7.55M$ -5.31M$ -1.82M$ 3.49M$ -7.96M
Operating Cash Flow$ -7.55M$ -667.00K$ -1.82M$ 3.49M$ -7.96M
Investing Cash Flow$ -71.79M$ -9.64M$ 13.75M$ 28.04M$ -1.60M
Financing Cash Flow$ 2.27M$ 128.40M$ 15.00K$ 528.00K$ 24.00K
Currency in USD

Climb Bio Earnings and Revenue History

Climb Bio Debt to Assets

Climb Bio Cash Flow

Climb Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis